(Q43696251)

25 November 2017

title

Effects of rosiglitazone on gene expression in subcutaneous adipose tissue in highly active antiretroviral therapy-associated lipodystrophy (English)

1 reference

25 November 2017

1 reference

5

1 reference

25 November 2017

10

Hubert Vidal

0 references

Rachel Fisher

object named as

Rachel M Fisher

4

0 references

Hannele Yki-Järvinen

12

object named as

Hannele Yki-Järvinen

1 reference

25 November 2017

11

Anders Hamsten

1 reference

25 November 2017

Jussi Sutinen

1

1 reference

25 November 2017

Katja Kannisto

2

1 reference

25 November 2017

Elena Korsheninnikova

3

1 reference

25 November 2017

Tuulikki Nyman

6

1 reference

25 November 2017

Antti Virkamäki

7

1 reference

25 November 2017

Tohru Funahashi

8

1 reference

25 November 2017

Yuji Matsuzawa

9

1 reference

25 November 2017

publication date

28 January 2004

1 reference

American Journal of Physiology - Endocrinology and Metabolism

25 November 2017

published in

1 reference

25 November 2017

volume

286

1 reference

25 November 2017

issue

6

1 reference

25 November 2017

page(s)

E941-9

1 reference

The adipocyte-secreted protein Acrp30 enhances hepatic insulin action

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00490.2003

ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00490.2003

The mechanisms of action of PPARs

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00490.2003

Peroxisome proliferator-activated receptor-gamma ligands inhibit adipocyte 11beta -hydroxysteroid dehydrogenase type 1 expression and activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00490.2003

Toxicological consequences of altered peroxisome proliferator-activated receptor gamma (PPARgamma) expression in the liver: insights from models of obesity and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00490.2003

Troglitazone action is independent of adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00490.2003

The HIV protease inhibitor indinavir impairs sterol regulatory element-binding protein-1 intranuclear localization, inhibits preadipocyte differentiation, and induces insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00490.2003

Adverse effects of antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00490.2003

Cytokines and macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00490.2003

Adipose tissue is required for the antidiabetic, but not for the hypolipidemic, effect of thiazolidinediones

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00490.2003

Endogenous glucose production is inhibited by the adipose-derived protein Acrp30

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00490.2003

Induction of adipocyte complement-related protein of 30 kilodaltons by PPARgamma agonists: a potential mechanism of insulin sensitization

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00490.2003

Regulation of glucose transport by pioglitazone in cultured muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00490.2003

Effect of metformin and rosiglitazone combination therapy in patients with type 2 diabetes mellitus: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00490.2003

Incidence of adipose tissue alterations in first-line antiretroviral therapy: the LipoICoNa Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00490.2003

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00490.2003

Adiponectin gene activation by thiazolidinediones requires PPAR gamma 2, but not C/EBP alpha-evidence for differential regulation of the aP2 and adiponectin genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00490.2003

Increased rates of lipolysis among human immunodeficiency virus-infected men receiving highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00490.2003

Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00490.2003

Effect of rosiglitazone treatment on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00490.2003

Effects of pioglitazone on metabolic parameters, body fat distribution, and serum adiponectin levels in Japanese male patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00490.2003

Induction of adiponectin, a fat-derived antidiabetic and antiatherogenic factor, by nuclear receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00490.2003

Expression of adipogenic transcription factors, peroxisome proliferator-activated receptor gamma co-activator 1, IL-6 and CD45 in subcutaneous adipose tissue in lipodystrophy associated with highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00490.2003

Regulation of adipocyte differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00490.2003

Rosiglitazone monotherapy is effective in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00490.2003

Diet-induced insulin resistance in mice lacking adiponectin/ACRP30

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00490.2003

PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00490.2003

The effects of rosiglitazone on insulin sensitivity, lipolysis, and hepatic and skeletal muscle triglyceride content in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00490.2003

Insulin and rosiglitazone regulation of lipolysis and lipogenesis in human adipose tissue in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00490.2003

Effect of rosiglitazone on glucose and non-esterified fatty acid metabolism in Type II diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00490.2003

Differential regulation of adiponectin secretion from cultured human omental and subcutaneous adipocytes: effects of insulin and rosiglitazone

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00490.2003

Reciprocal association of C-reactive protein with adiponectin in blood stream and adipose tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00490.2003

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00490.2003

Rosiglitazone short-term monotherapy lowers fasting and post-prandial glucose in patients with type II diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00490.2003

Metabolic gene expression in fetal and failing human heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00490.2003

Regulation of gene expression by activation of the peroxisome proliferator-activated receptor gamma with rosiglitazone (BRL 49653) in human adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00490.2003

Effects of antiretroviral drug combinations on the differentiation of adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00490.2003

Properties of four acute phase proteins: C-reactive protein, serum amyloid A protein, alpha 1-acid glycoprotein, and fibrinogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00490.2003

Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00490.2003

Down-regulation by troglitazone of hepatic tumor necrosis factor-alpha and interleukin-6 mRNA expression in a murine model of non-insulin-dependent diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00490.2003

PPAR-gamma: adipogenic regulator and thiazolidinedione receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00490.2003

Increased fat accumulation in the liver in HIV-infected patients with antiretroviral therapy-associated lipodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00490.2003

Circulating concentration of adiponectin and its expression in subcutaneous adipose tissue in patients with highly active antiretroviral therapy-associated lipodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00490.2003

Liver-fat accumulation and insulin resistance in obese women with previous gestational diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00490.2003

Increased risk of lipodystrophy when nucleoside analogue reverse transcriptase inhibitors are included with protease inhibitors in the treatment of HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00490.2003

Nevirapine-containing antiretroviral therapy in HIV-1 infected patients results in an anti-atherogenic lipid profile

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00490.2003

Clinical evaluation and management of metabolic and morphologic abnormalities associated with human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00490.2003

PPARgamma induces the insulin-dependent glucose transporter GLUT4 in the absence of C/EBPalpha during the conversion of 3T3 fibroblasts into adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00490.2003

The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00490.2003

Synthetic peroxisome proliferator-activated receptor-gamma agonist, rosiglitazone, increases plasma levels of adiponectin in type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00490.2003

Prior thiazolidinedione treatment preserves insulin sensitivity in normal rats during acute fatty acid elevation: role of the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00490.2003

Antiretroviral treatment for adult HIV infection in 2002: updated recommendations of the International AIDS Society-USA Panel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00490.2003

Action of insulin on glucose metabolism in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00490.2003

Troglitazone induces GLUT4 translocation in L6 myotubes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00490.2003

Guidelines for the Evaluation and Management of Dyslipidemia in Human Immunodeficiency Virus (HIV)-Infected Adults Receiving Antiretroviral Therapy: Recommendations of the HIV Medicine Association of the Infectious Disease Society of America and the

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00490.2003

10.1152/AJPENDO.00490.2003

21 January 2018

Identifiers

DOI

1 reference

25 November 2017

1 reference